Magnetic resonance imaging in rectal cancer

Magnetic Resonance Imaging Clinics of North America

Volumn 22, Issue 2, 2014, Pages 165-190

  Furey, Elizabeth ^a   Jhaveri, Kartik S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Circumferential resection margin; Magnetic resonance imaging; Preoperative staging; Rectal anatomy; Rectal cancer

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT IDENTIFICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; REVIEW; SURGICAL ANATOMY; SURGICAL APPROACH; TREATMENT RESPONSE; ALGORITHM; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; MALE; PATHOLOGY; PROCEDURES; RECTUM; RECTUM TUMOR; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; RECTAL NEOPLASMS; RECTUM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84899677618     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2014.01.004     Document Type: Review

References (109)

1. Maier A., Fuchsjager M. Preoperative staging of rectal cancer. Eur J Radiol 2003, 47(2):89-97.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11-30.
3. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy forrectal cancer. NEngl J Med 2004, 351(17):1731-1740.
4. Heald R.J., Moran B.J., Ryall R.D., et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998, 133(8):894-899.
5. Enker W.E. Total mesorectal excision-the new golden standard of surgery for rectal cancer. Ann Med 1997, 29(2):127-133.
6. Shihab O.C., Moran B.J., Heald R.J., et al. MRI staging of low rectal cancer. Eur Radiol 2009, 19(3):643-650.
7. Kosinski L., Habr-Gama A., Ludwig K., et al. Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. CA Cancer J Clin 2012, 62(3):173-202.
8. Hermanek P., Junginger T. The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol 2005, 9(3):193-199. [discussion: 199-200].
9. Quirke P., Durdey P., Dixon M.F., et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986, 2(8514):996-999.
10. Garcia-Aguilar J., Pollack J., Lee S.H., et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002, 45(1):10-15.
11. Fernandez-Esparrach G., Ayuso-Colella J.R., Sendino O., et al. EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study. Gastrointest Endosc 2011, 74(2):347-354.
12. Cartana E.T., Parvu D., Saftoiu A. Endoscopic ultrasound: current role and future perspectives in managing rectal cancer patients. JGastrointestin Liver Dis 2011, 20(4):407-413.
13. Beets-Tan R.G., Beets G.L. Rectal cancer: review with emphasis on MR imaging. Radiology 2004, 232(2):335-346.
14. Bipat S., Glas A.S., Slors F.J., et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology 2004, 232(3):773-783.
15. Maizlin Z.V., Brown J.A., So G., et al. Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer?. Dis Colon Rectum 2010, 53(3):308-314.
16. Brown G., Richards C.J., Newcombe R.G., et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999, 211(1):215-222.
17. Brown G., Daniels I.R., Richardson C., et al. Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer. Br J Radiol 2005, 78(927):245-251.
18. Kaur H., Choi H., You Y.N., et al. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 2012, 32(2):389-409.
19. Kim H., Lim J.S., Choi J.Y., et al. Rectal cancer: comparison of accuracy of local-regional staging with two- and three-dimensional preoperative 3-T MR imaging. Radiology 2010, 254(2):485-492.
20. Hori M., Kim T., Onishi H., et al. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T-initial experience. Radiology 2011, 258(1):154-163.
21. Blomqvist L., Holm T., Rubio C., et al. Rectal tumours-MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections. A comparative study. Acta Radiol 1997, 38(3):437-444.
22. Dewhurst C., Rosen M.P., Blake M.A., et al. ACR Appropriateness Criteria pretreatment staging of colorectal cancer. JAm Coll Radiol 2012, 9(11):775-781.
23. Brown G., Daniels I.R. Preoperative staging of rectal cancer: the MERCURY research project. Recent Results Cancer Res 2005, 165:58-74.
24. Suzuki C., Torkzad M.R., Tanaka S., et al. The importance of rectal cancer MRI protocols on interpretation accuracy. World J Surg Oncol 2008, 6:89.
25. MERCURY Study Group Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007, 243(1):132-139.
26. Rao S.X., Zeng M.S., Chen C.Z., et al. The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol 2008, 65(2):299-303.
27. Ichikawa T., Erturk S.M., Motosugi U., et al. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006, 187(1):181-184.
28. Lim K.S., Tan C.H. Diffusion-weighted MRI of adult male pelvic cancers. Clin Radiol 2012, 67(9):899-908.
29. Mizukami Y., Ueda S., Mizumoto A., et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg 2011, 35(4):895-899.
30. Jao S.Y., Yang B.Y., Weng H.H., et al. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer. Colorectal Dis 2010, 12(11):1139-1148.
31. Vliegen R.F., Beets G.L., von Meyenfeldt M.F., et al. Rectal cancer: MR imaging in local staging-is gadolinium-based contrast material helpful?. Radiology 2005, 234(1):179-188.
32. Brown G., Kirkham A., Williams G.T., et al. High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 2004, 182(2):431-439.
33. Dujovny N., Quiros R.M., Saclarides T.J. Anorectal anatomy and embryology. Surg Oncol Clin N Am 2004, 13(2):277-293.
34. Gollub M.J., Maas M., Weiser M., et al. Recognition of the anterior peritoneal reflection at rectal MRI. AJR Am J Roentgenol 2013, 200(1):97-101.
35. Salerno G., Daniels I.R., Moran B.J., et al. Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience. Clin Radiol 2006, 61(11):916-923.
36. Klessen C., Rogalla P., Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol 2007, 17(2):379-389.
37. Zhang X.M., Zhang H.L., Yu D., et al. 3-T MRI of rectal carcinoma: preoperative diagnosis, staging, and planning of sphincter-sparing surgery. AJR Am J Roentgenol 2008, 190(5):1271-1278.
38. Beets-Tan R.G., Beets G.L., Borstlap A.C., et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI?. Abdom Imaging 2000, 25(5):533-541.
39. Taylor F.G., Swift R.I., Blomqvist L., et al. Asystematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol 2008, 191(6):1827-1835.
40. Brown G., Radcliffe A.G., Newcombe R.G., et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003, 90(3):355-364.
41. Compton C.C., Greene F.L. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004, 54(6):295-308.
42. Beets-Tan R.G., Beets G.L., Vliegen R.F., et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001, 357(9255):497-504.
43. Willett C.G., Badizadegan K., Ancukiewicz M., et al. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?. Dis Colon Rectum 1999, 42(2):167-173.
44. Cawthorn S.J., Parums D.V., Gibbs N.M., et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990, 335(8697):1055-1059.
45. Merkel S., Mansmann U., Siassi M., et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001, 16(5):298-304.
46. Pollheimer M.J., Kornprat P., Pollheimer V.S., et al. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer. Int J Colorectal Dis 2010, 25(2):187-196.
47. Taylor F.G., Quirke P., Heald R.J., et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 2011, 253(4):711-719.
48. Beaumont C., Pandey T., Gaines Fricke R., et al. MR evaluation of rectal cancer: current concepts. Curr Probl Diagn Radiol 2013, 42(3):99-112.
49. Taylor F.G., Quirke P., Heald R.J., et al. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg 2011, 98(6):872-879.
50. Horn A., Dahl O., Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991, 34(9):798-804.
51. Smith N.J., Barbachano Y., Norman A.R., et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008, 95(2):229-236.
52. Engelen S.M., Beets-Tan R.G., Lahaye M.J., et al. Location of involved mesorectal and extramesorectal lymph nodes in patients with primary rectal cancer: preoperative assessment with MR imaging. Eur J Surg Oncol 2008, 34(7):776-781.
53. Wang C., Zhou Z.G., Yu Y.Y., et al. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer. Eur J Surg Oncol 2007, 33(4):463-467.
54. Luna-Perez P., Corral P., Labastida S., et al. Inguinal lymph node metastases from rectal adenocarcinoma. JSurg Oncol 1999, 70(3):177-180.
55. Sugihara K., Kobayashi H., Kato T., et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 2006, 49(11):1663-1672.
56. Dworak O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc 1989, 3(2):96-99.
57. Kotanagi H., Fukuoka T., Shibata Y., et al. The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer. JSurg Oncol 1993, 54(4):252-254.
58. Brown G., Richards C.J., Bourne M.W., et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003, 227(2):371-377.
59. Kim J.H., Beets G.L., Kim M.J., et al. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?. Eur J Radiol 2004, 52(1):78-83.
60. Matsuoka H., Nakamura A., Sugiyama M., et al. MRI diagnosis of mesorectal lymph node metastasis in patients with rectal carcinoma. What is the optimal criterion?. Anticancer Res 2004, 24(6):4097-4101.
61. Koh D.M., Brown G., Temple L., et al. Distribution of mesorectal lymph nodes in rectal cancer: invivo MR imaging compared with histopathological examination. Initial observations. Eur Radiol 2005, 15(8):1650-1657.
62. Mir N., Sohaib S.A., Collins D., et al. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. JMed Imaging Radiat Oncol 2010, 54(4):358-364.
63. Will O., Purkayastha S., Chan C., et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 2006, 7(1):52-60.
64. Lahaye M.J., Beets G.L., Engelen S.M., et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?. Radiology 2009, 252(1):81-91.
65. Koh D.M., George C., Temple L., et al. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. AJR Am J Roentgenol 2010, 194(6):W505-W513.
66. Lambregts D.M., Beets G.L., Maas M., et al. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg 2011, 253(3):539-545.
67. Lambregts D.M., Heijnen L.A., Maas M., et al. Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria. Abdom Imaging 2013, 38(4):720-727.
68. Salerno G., Daniels I.R., Brown G., et al. Variations in pelvic dimensions do not predict the risk of circumferential resection margin (CRM) involvement in rectal cancer. World J Surg 2007, 31(6):1313-1320.
69. Akagi Y., Shirouzu K., Ogata Y., et al. Oncologic outcomes of intersphincteric resection without preoperative chemoradiotherapy for very low rectal cancer. Surg Oncol 2013, 22(2):144-149.
70. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. NEngl J Med 2001, 345(9):638-646.
71. Nagtegaal I.D., van de Velde C.J., Marijnen C.A., et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. JClin Oncol 2005, 23(36):9257-9264.
72. Guillou P.J., Quirke P., Thorpe H., et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005, 365(9472):1718-1726.
73. Marr R., Birbeck K., Garvican J., et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 2005, 242(1):74-82.
74. Shihab O.C., Brown G., Daniels I.R., et al. Patients with low rectal cancer treated by abdominoperineal excision have worse tumors and higher involved margin rates compared with patients treated by anterior resection. Dis Colon Rectum 2010, 53(1):53-56.
75. Hussain S.M., Outwater E.K., Siegelman E.S. Mucinous versus nonmucinous rectal carcinomas: differentiation with MR imaging. Radiology 1999, 213(1):79-85.
76. Kim D.J., Kim J.H., Lim J.S., et al. Restaging of rectal cancer with mr imaging after concurrent chemotherapy and radiation therapy. Radiographics 2010, 30(2):503-516.
77. Kim S.H., Lee J.M., Park H.S., et al. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. JMagn Reson Imaging 2009, 29(5):1093-1101.
78. Patel U.B., Blomqvist L.K., Taylor F., et al. MRI after treatment of locally advanced rectal cancer: how to report tumor response-the MERCURY experience. AJR Am J Roentgenol 2012, 199(4):W486-W495.
79. Del Vescovo R., Trodella L.E., Sansoni I., et al. MR imaging of rectal cancer before and after chemoradiation therapy. Radiol Med 2012, 117(7):1125-1138.
80. Kuo L.J., Chern M.C., Tsou M.H., et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005, 48(1):23-28.
81. Chen C.C., Lee R.C., Lin J.K., et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?. Dis Colon Rectum 2005, 48(4):722-728.
82. Valentini V., Coco C., Cellini N., et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 1998, 40(5):1067-1075.
83. Vliegen R.F., Beets G.L., Lammering G., et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 2008, 246(2):454-462.
84. Dresen R.C., Beets G.L., Rutten H.J., et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?. Radiology 2009, 252(1):71-80.
85. Alberda W.J., Dassen H.P., Dwarkasing R.S., et al. Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2013, 28(4):573-580.
86. Lambrecht M., Vandecaveye V., De Keyzer F., et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys 2012, 82(2):863-870.
87. Kim S.H., Lee J.M., Hong S.H., et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009, 253(1):116-125.
88. Lambregts D.M., Vandecaveye V., Barbaro B., et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011, 18(8):2224-2231.
89. Hein P.A., Kremser C., Judmaier W., et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003, 45(3):214-222.
90. Intven M., Reerink O., Philippens M.E. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther Onkol 2013, 189(2):117-122.
91. Jung S.H., Heo S.H., Kim J.W., et al. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. JMagn Reson Imaging 2012, 35(1):110-116.
92. Kremser C., Judmaier W., Hein P., et al. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 2003, 179(9):641-649.
93. Sun Y.S., Zhang X.P., Tang L., et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010, 254(1):170-178.
94. Engin G., Sharifov R., Gural Z., et al. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?. Diagn Interv Radiol 2012, 18(6):574-581.
95. DeVries A.F., Kremser C., Hein P.A., et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003, 56(4):958-965.
96. Dzik-Jurasz A., Domenig C., George M., et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002, 360(9329):307-308.
97. Boone D., Taylor S.A., Halligan S. Diffusion weighted MRI: overview and implications for rectal cancer management. Colorectal Dis 2013, 15(6):655-661.
98. Grillo-Ruggieri F., Mantello G., Berardi R., et al. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Dis Colon Rectum 2007, 50(10):1594-1603.
99. Dworak O., Keilholz L., Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997, 12(1):19-23.
100. Thompson W.M., Halvorsen R.A., Foster W.L., et al. Preoperative and postoperative CT staging of rectosigmoid carcinoma. AJR Am J Roentgenol 1986, 146(4):703-710.
101. Ebner F., Kressel H.Y., Mintz M.C., et al. Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. Radiology 1988, 166(2):333-340.
102. Glazer H.S., Lee J.K., Levitt R.G., et al. Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology 1985, 156(3):721-726.
103. Kinkel K., Tardivon A.A., Soyer P., et al. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. Radiology 1996, 200(2):453-458.
104. Messiou C., Chalmers A.G., Boyle K., et al. Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol 2008, 81(966):468-473.
105. Muller-Schimpfle M., Brix G., Layer G., et al. Recurrent rectal cancer: diagnosis with dynamic MR imaging. Radiology 1993, 189(3):881-889.
106. Dicle O., Obuz F., Cakmakci H. Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 1999, 72(864):1155-1159.
107. Robinson P., Carrington B.M., Swindell R., et al. Recurrent or residual pelvic bowel cancer: accuracy of MRI local extent before salvage surgery. Clin Radiol 2002, 57(6):514-522.
108. Messiou C., Chalmers A., Boyle K., et al. Surgery for recurrent rectal carcinoma: the role of preoperative magnetic resonance imaging. Clin Radiol 2006, 61(3):250-258.
109. Sagar P.M., Pemberton J.H. Surgical management of locally recurrent rectal cancer. Br J Surg 1996, 83(3):293-304.